Literature DB >> 35795718

Extent of Left Atrial Fibrosis Correlates with Descending Aorta Proximity at 3D Late Gadolinium Enhancement Cardiac MRI in Patients with Atrial Fibrillation.

Luuk H G A Hopman1, Pranav Bhagirath1, Mark J Mulder1, Iris N Eggink1, Albert C van Rossum1, Cornelis P Allaart1, Marco J W Götte1.   

Abstract

Purpose: To determine whether the distance between the descending aorta and left atrial (LA) wall correlates with the amount of fibrosis quantified in the posterior left inferior pulmonary vein (LIPV) area of the LA in patients with atrial fibrillation (AF). Materials and
Methods: In this retrospective study, patients with AF underwent cardiac MRI in sinus rhythm prior to a pulmonary vein isolation procedure (July 2018 to February 2020). The mean distance (distancemean) and shortest distance (distanceshort) between the descending aorta and the LA wall were measured on three-dimensional (3D) contrast-enhanced MR angiograms; distancemean was defined as the average of five measurements at different levels between the descending aorta and the LA wall. The extent of LA fibrosis, both global fibrosis and regional fibrosis within the LIPV area, was derived from postprocessed, 3D, late gadolinium-enhanced images. Associations between the extent of fibrosis and the proximity of the descending aorta were analyzed by using correlative and multivariable analyses.
Results: A total of 47 (mean age, 60 years ± 8 [standard deviation]; 31 men) patients were included for analysis. The extent of fibrosis in the posterior LIPV area was correlated with the distancemean (r s = -0.48; P < .01) and distanceshort (r s = -0.49; P < .01). Patients with a short distance between the descending aorta and LA wall (defined as a distanceshort < 2 mm) had a higher percentage of fibrosis in the posterior LIPV area than patients with a distanceshort greater than 2 mm (38.7% ± 22.7 vs 21.2% ± 17.8; P < .01).
Conclusion: The distance between the descending aorta and LA was correlated with the extent of quantified fibrosis within the posterior LIPV area.Keywords: MRI, Cardiac, Left Atrium Supplemental material is available for this article. © RSNA, 2022. 2022 by the Radiological Society of North America, Inc.

Entities:  

Keywords:  Cardiac; Left Atrium; MRI

Year:  2022        PMID: 35795718      PMCID: PMC8893208          DOI: 10.1148/ryct.210192

Source DB:  PubMed          Journal:  Radiol Cardiothorac Imaging        ISSN: 2638-6135


  34 in total

1.  Relationship of the esophagus and aorta to the left atrium and pulmonary veins: implications for catheter ablation of atrial fibrillation.

Authors:  Ricardo C Cury; Suhny Abbara; Steven Schmidt; Zachary J Malchano; Petr Neuzil; Jiri Weichet; Maros Ferencik; Udo Hoffmann; Jeremy N Ruskin; Thomas J Brady; Vivek Y Reddy
Journal:  Heart Rhythm       Date:  2005-12       Impact factor: 6.343

2.  Extent and spatial distribution of left atrial arrhythmogenic sites, late gadolinium enhancement at magnetic resonance imaging, and low-voltage areas in patients with persistent atrial fibrillation: comparison of imaging vs. electrical parameters of fibrosis and arrhythmogenesis.

Authors:  Juan Chen; Thomas Arentz; Hubert Cochet; Björn Müller-Edenborn; Steven Kim; Zoraida Moreno-Weidmann; Jan Minners; Peter Kohl; Heiko Lehrmann; Juergen Allgeier; Dietmar Trenk; Meleze Hocini; Pierre Jais; Michel Haissaguerre; Amir Jadidi
Journal:  Europace       Date:  2019-10-01       Impact factor: 5.214

Review 3.  Assessment of myocardial fibrosis with cardiovascular magnetic resonance.

Authors:  Nathan Mewton; Chia Ying Liu; Pierre Croisille; David Bluemke; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2011-02-22       Impact factor: 24.094

Review 4.  Assessment of Left Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging: Methodology and Clinical Implications.

Authors:  Johannes Siebermair; Eugene G Kholmovski; Nassir Marrouche
Journal:  JACC Clin Electrophysiol       Date:  2017-08-21

Review 5.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

Authors:  Brett Burstein; Stanley Nattel
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

6.  Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.

Authors:  Nassir F Marrouche; David Wilber; Gerhard Hindricks; Pierre Jais; Nazem Akoum; Francis Marchlinski; Eugene Kholmovski; Nathan Burgon; Nan Hu; Lluis Mont; Thomas Deneke; Mattias Duytschaever; Thomas Neumann; Moussa Mansour; Christian Mahnkopf; Bengt Herweg; Emile Daoud; Erik Wissner; Paul Bansmann; Johannes Brachmann
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

7.  Influence of left atrium anatomical contact area in persistent atrial fibrillation-relationship between low-voltage area and fractionated electrogram.

Authors:  Yuichi Hori; Shiro Nakahara; Tohru Kamijima; Naofumi Tsukada; Akiko Hayashi; Sayuki Kobayashi; Yoshihiko Sakai; Isao Taguchi
Journal:  Circ J       Date:  2014-07-09       Impact factor: 2.993

8.  Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

Authors:  Robert S Oakes; Troy J Badger; Eugene G Kholmovski; Nazem Akoum; Nathan S Burgon; Eric N Fish; Joshua J E Blauer; Swati N Rao; Edward V R DiBella; Nathan M Segerson; Marcos Daccarett; Jessiciah Windfelder; Christopher J McGann; Dennis Parker; Rob S MacLeod; Nassir F Marrouche
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

9.  Algorithms for left atrial wall segmentation and thickness - Evaluation on an open-source CT and MRI image database.

Authors:  Rashed Karim; Lauren-Emma Blake; Jiro Inoue; Qian Tao; Shuman Jia; R James Housden; Pranav Bhagirath; Jean-Luc Duval; Marta Varela; Jonathan M Behar; Loïc Cadour; Rob J van der Geest; Hubert Cochet; Maria Drangova; Maxime Sermesant; Reza Razavi; Oleg Aslanidi; Ronak Rajani; Kawal Rhode
Journal:  Med Image Anal       Date:  2018-08-24       Impact factor: 8.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.